0.73

12.99% -0.109

After Hours: .735 0.005 +0.68%

Cardio Diagnostics Holdings Inc (CDIO)

Overview News Price History Financials Discussions Forecast

Cardio Diagnostics Holdings Inc stock is currently priced at $0.73, with a 24-hour trading volume of 645.11K. It has seen a -12.99% decreased in the last 24 hours and a -28.43% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.847 pivot point. If it approaches the $0.7262 support level, significant changes may occur.

Previous Close:

$0.839

Open:

$0.82

24h Volume:

645.11K

Market Cap:

$15.76M

Revenue:

Net Income/Loss:

$-9.37M

P/E Ratio:

-1.0233

EPS:

-0.7134

Net Cash Flow:

$-7.34M

1W Performance:

-19.35%

1M Performance:

-28.43%

6M Performance:

-26.26%

1Y Performance:

-50.68%

1D Range:

$0.69

$0.8399

52W Range:

$0.171

$3.56

Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile

Name

Cardio Diagnostics Holdings Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

855 226 9991

Address

400 North Abderdeen Street, Suite 900, Chicago

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CDIO's Discussions on Twitter

Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News

Taking on analysts' expectations and winning: Cardio Diagnostics Holdings Inc (CDIO) – Sete News - SETE News

SETE News

Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail ... - Yahoo Finance

Yahoo Finance

Successful Penny Stocks Trader Tips, 3 To Use

PennyStocks

New Study Shows Cardio Diagnosticsâ€™ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over ... - Marketscreener.com

Marketscreener.com

Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers ... - Business Wire

Business Wire

As the Use of AI In Healthcare Grows, Cardio Diagnostic Is Using It In Quest to Help Prevent Cardiovascul - Benzinga

Benzinga

Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data

Cardio Diagnostics Holdings Inc (CDIO) Net Income 2024

CDIO net income (TTM) was -$9.37 million for the quarter ending September 30, 2023, a -293.79% decrease year-over-year.

Cardio Diagnostics Holdings Inc (CDIO) Cash Flow 2024

CDIO recorded a free cash flow (TTM) of -$7.34 million for the quarter ending September 30, 2023, a -246.04% decrease year-over-year.

Cardio Diagnostics Holdings Inc (CDIO) Earnings per Share 2024

CDIO earnings per share (TTM) was -$0.9099 for the quarter ending September 30, 2023, a -263.96% decline year-over-year.

Cardio Diagnostics Holdings Inc Stock (CDIO) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Lau Stanley K.	Director	Mar 31 '24	Option Exercise	1.42	8,803	12,500	100,325
Intrater James	Director	Mar 31 '24	Option Exercise	1.42	8,803	12,500	71,596
Levy Oded	Director	Mar 31 '24	Option Exercise	1.42	8,803	12,500	71,596
Lau Stanley K.	Director	Jan 31 '24	Option Exercise	2.18	917	1,999	91,522
Lau Stanley K.	Director	Dec 31 '23	Option Exercise	2.49	6,626	16,499	90,605
Sim Brandon	Director	Dec 31 '23	Option Exercise	2.49	5,020	12,500	62,793
Intrater James	Director	Dec 31 '23	Option Exercise	2.49	5,020	12,500	62,793
Levy Oded	Director	Dec 31 '23	Option Exercise	2.49	5,020	12,500	62,793
Lau Stanley K.	Director	Oct 31 '23	Option Exercise	0.30	6,631	2,000	83,979
Lau Stanley K.	Director	Sep 30 '23	Option Exercise	0.34	42,647	14,500	77,348

Cardio Diagnostics Holdings, Inc., a biotechnology company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks. The company was founded in 2017 and is headquartered in Chicago, Illinois.